Skip to main content
logo
Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.665
-0.110 (-3.96%)
Sep 11, 2026, 11:39 AM HKT

HKG:6922 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
84.8495.2753.5340.9527.1522.43
Revenue Growth
-10.95%77.97%30.72%50.83%21.06%147.69%
Gross Profit
57.5263.9838.4131.0519.3615.55
Operating Income
-34.38-43.43-130.33-119.77-128.9-78.87
Net Income
-29.43-38.17-104.37-97.49-112.22-101.87
Earnings Per Share
-0.12-0.16-0.44-0.41-0.49-0.45
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
59.2735.7146.26104.46228.34159.3
Total Debt
40.5326.243.3211.0111.379
Net Cash (Debt)
18.759.512.9493.44216.97150.3
Net Cash Growth
97.20%223.44%-96.86%-56.93%44.36%360.28%
Net Cash Per Share
0.080.040.010.390.950.66

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--5.82-82.91-95.89-96.94-62.49
Capital Expenditures
--0.77-1.88-15.1-7.01-12.44
Free Cash Flow
--6.59-84.79-111-103.95-74.93
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
67.80%67.16%71.75%75.83%71.32%69.32%
Operating Margin
-40.52%-45.59%-243.46%-292.48%-474.77%-351.68%
Pretax Margin
-39.40%-46.66%-207.62%-258.23%-435.80%-564.06%
Profit Margin
-34.69%-40.06%-194.96%-238.06%-413.36%-454.26%
FCF Margin
--6.92%-158.39%-271.05%-382.87%-334.11%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
6.6615.5234.2599.75137.58-